undamentalytics Newsletter

Qiagen N.V. balance sheet

At the end of fiscal 2025, Qiagen N.V. had total assets of $6.28bn and shareholders' equity of $3.78bn. It held $839m in cash against $1.65bn of debt: net debt of $815m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Qiagen N.V.: balance sheet, annual
Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents8268282213943303932904396581,159624598881731668664839
Receivables194197231251260265274278329352385381362324382349403
Inventory131127132135128132137137156163171291328358398279302
Total current assets1,3331,3657459939211,1499611,0381,6482,1551,5701,6242,1102,3942,1481,9601,995
Goodwill1,3371,3521,7341,7601,8561,8881,8761,9262,0132,1092,1412,3642,3512,3532,4762,4252,701
Total assets3,7963,9143,7304,0884,0884,4544,1794,3085,0395,7485,2365,8706,1476,2886,1155,6906,281
Accounts payable444860515146525159698511810199848373
Deferred revenue (current)————————494549576369667179
Total current liabilities3763884522673374322683083259729515721,5179751,0791,042512
Short-term debt50762101310—0503285438483905885520
Long-term debt8707974468468451,0411,0491,0671,7581,6711,4211,8801,0941,4729228401,654
Total debt9208735908478451,1721,0491,0671,7582,1741,7061,9231,9421,8611,5101,3921,654
Shareholders' equity2,2912,4762,5482,7152,7142,6502,5662,6072,5412,6352,5372,7983,0973,4673,8083,5673,778
Net debt (negative = net cash)94453694535157797596281,1011,0151,0831,3251,0611,131842728815
Shares outstanding232m233m234m236m—————————————

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BIO vs QGENFTRE vs QGENMEDP vs QGEN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Qiagen N.V.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Qiagen N.V.